Discover how a cutting-edge quality improvement initiative is transforming lung cancer care by optimizing biomarker testing to deliver faster, more accurate treatment decisions.
OncoLens showcases the remarkable impact of a multidisciplinary quality improvement program (QIP) designed to elevate comprehensive lung cancer biomarker testing rates. Focused on advanced non-small cell lung cancer, the initiative—implemented by Bon Secours Mercy Health—integrated innovative liquid biopsy techniques with traditional tissue sampling to overcome testing limitations and reduce delays. By updating pathology-driven testing panels and streamlining workflows through a single reference lab partnership, the program not only boosted comprehensive testing rates but also significantly shortened the time from diagnosis to actionable results. This evidence-based approach not only enhances targeted therapy selection but also improves overall patient outcomes, making it a compelling model for health systems aiming to deliver state-of-the-art oncology care. Download this case study to learn more.
Complete our quick form to download and read the full case study.
Latest
